| Line item | 2026-03-31 FY | 2025-03-31 FY | 2024-03-31 FY | 2023-03-31 FY | 2022-03-31 FY | 2021-03-31 FY |
|---|---|---|---|---|---|---|
| Revenue | – | – | – | – | – | – |
| Cost of Revenue | – | – | – | – | – | – |
| Gross Profit | – | – | – | – | – | – |
| Operating Expenses | $319.92M | $261.63M | $234.77M | $177.08M | $118.31M | $79.95M |
| R&D | $221.18M | $189.45M | $174.96M | $126.53M | $79.55M | $56.75M |
| SG&A | $98.73M | $72.18M | $59.81M | $50.55M | $38.77M | $23.20M |
| Operating Income | -$319.92M | -$261.63M | -$234.77M | -$177.08M | -$118.31M | -$79.95M |
| Interest Expense | $6.80M | $5.78M | $4.50M | $1.96M | $0.00 | $818.00K |
| Tax Expense | -$551.00K | $468.00K | $408.00K | $288.00K | $0.00 | $0.00 |
| Net Income | -$313.94M | -$247.30M | -$215.79M | -$174.28M | -$118.04M | -$80.87M |
| EPS (basic) | -3.3800 | -3.0700 | -3.2400 | -2.9900 | -2.2600 | -1.7500 |
| EPS (diluted) | -3.3800 | -3.0700 | -3.2400 | -2.9900 | -2.2600 | -1.7500 |
| Shares (diluted) | $92.80M | $80.56M | $66.57M | $58.21M | $52.21M | $46.25M |